Drug Trial Radar · NCT04010305
Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia
Last checked: Nov 20, 2026Latest source record: Aug 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
135
Actual
Start
May 22, 2019
Primary completion
Jul 31, 2019
Study completion Jul 31, 2019
Sponsor
- Lead sponsor
- BioXcel Therapeutics IncIndustry
- Sponsor type
- Industry
- Collaborators
- Cognitive Research Corporation
- First posted
- Jul 8, 2019
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a two-stage adaptive Phase Ib trial design, that will identify two doses (lowest dose with clinical benefit and highest safe dose) in a first stage and better evaluate safety, tolerability and variability of effect in the second stage.
Conditions
- Agitation
- Schizophrenia
Interventions
Sublingual film containing BXCL501 (Dexmedetomidine)Drug
Sublingual film containing BXCL501 (Dexmedetomidine) for the treatment of agitation associated with Schizophrenia
Placebo filmDrug
Placebo film for BXCL501
Primary outcomes
What the sponsor says the trial is designed to measure.
- PANSS-EC Change From BaselineTime frame: 120 minutes
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
BioXcel Clinical Research Site
Little Rock, Arkansas
BioXcel Clinical Research Site
Cerritos, California
BioXcel Clinical Research Site
Lemon Grove, California
BioXcel Clinical Research Site
Long Beach, California
BioXcel Clinical Research Site
Orange, California
BioXcel Clinical Research Site
Miami Lakes, Florida
BioXcel Clinical Research Site
Atlanta, Georgia
BioXcel Clinical Research Site
Gaithersburg, Maryland
BioXcel Clinical Research Site
Flowood, Mississippi
BioXcel Clinical Research Site
Berlin, New Jersey
BioXcel Clinical Research Site
Austin, Texas
BioXcel Clinical Research Site
Richardson, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.